Waldencast plc [WALD] vs Nu Skin Enterprises [NUS] Detailed Stock Comparison

Waldencast plc

NASDAQ

Nu Skin Enterprises

NYSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Waldencast plc wins in 4 metrics, Nu Skin Enterprises wins in 12 metrics, with 0 ties. Nu Skin Enterprises appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Waldencast plc	Nu Skin Enterprises	Better
P/E Ratio (TTM)	N/A	6.00	N/A
Price-to-Book Ratio	0.26	0.76	Waldencast plc
Debt-to-Equity Ratio	24.95	43.06	Waldencast plc
PEG Ratio	-15.60	-0.05	Waldencast plc
EV/EBITDA	676.12	4.31	Nu Skin Enterprises
Profit Margin (TTM)	-15.50%	6.20%	Nu Skin Enterprises
Operating Margin (TTM)	-18.31%	7.97%	Nu Skin Enterprises
EBITDA Margin (TTM)	N/A	7.97%	N/A
Return on Equity	-6.49%	13.68%	Nu Skin Enterprises
Return on Assets (TTM)	-3.32%	3.95%	Nu Skin Enterprises
Free Cash Flow (TTM)	$-11.83M	$70.16M	Nu Skin Enterprises
Dividend Yield	N/A	2.32%	N/A
1-Year Return	-57.67%	50.50%	Nu Skin Enterprises
Price-to-Sales Ratio (TTM)	0.70	0.37	Nu Skin Enterprises
Enterprise Value	$409.73M	$675.49M	Nu Skin Enterprises
EV/Revenue Ratio	1.50	0.42	Nu Skin Enterprises
Gross Profit Margin (TTM)	N/A	68.82%	N/A
Revenue per Share (TTM)	$2	$33	Nu Skin Enterprises
Earnings per Share (Diluted)	$-0.39	$2.03	Nu Skin Enterprises
Beta (Stock Volatility)	-0.53	0.89	Waldencast plc

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Waldencast plc vs Nu Skin Enterprises Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Waldencast plc	6.71%	-8.02%	-18.13%	-37.92%	-53.00%	-60.16%
Nu Skin Enterprises	2.08%	-1.23%	44.54%	50.31%	57.18%	83.54%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Waldencast plc	-57.67%	-82.87%	-84.87%	-84.87%	-84.87%	-84.87%
Nu Skin Enterprises	50.50%	-70.26%	-75.80%	-72.49%	-53.85%	-44.00%

Performance & Financial Health Analysis: Waldencast plc vs Nu Skin Enterprises

Metric	WALD	NUS
Market Information
Market Cap i	$32.08M	$380.88M
Market Cap Category	Micro cap	Small cap
10 Day Avg. Volume i	870,850	576,200
90 Day Avg. Volume i	385,483	595,333
Last Close	$1.59	$12.29
52 Week Range	$1.48 - $4.39	$5.32 - $12.41
% from 52W High	-63.82%	-0.97%
All-Time High	$12.10 (Oct 03, 2022)	$140.50 (Jan 13, 2014)
% from All-Time High	-86.86%	-91.25%
Growth Metrics
Quarterly Revenue Growth	0.31%	-0.12%
Quarterly Earnings Growth	N/A	-0.12%
Financial Health
Profit Margin (TTM) i	-0.16%	0.06%
Operating Margin (TTM) i	-0.18%	0.08%
Return on Equity (TTM) i	-0.06%	0.14%
Debt to Equity (MRQ) i	24.95	43.06
Cash & Liquidity
Book Value per Share (MRQ)	$5.91	$15.91
Cash per Share (MRQ)	$0.13	$5.38
Operating Cash Flow (TTM) i	$-8,820,000	$93.40M
Levered Free Cash Flow (TTM) i	$8.34M	$175.51M
Dividends
Last 12-Month Dividend Yield i	N/A	2.32%
Last 12-Month Dividend i	N/A	$0.18

Valuation & Enterprise Metrics Analysis: Waldencast plc vs Nu Skin Enterprises

Metric	WALD	NUS
Price Ratios
P/E Ratio (TTM) i	N/A	6.00
Forward P/E i	-15.60	11.70
PEG Ratio i	-15.60	-0.05
Price to Sales (TTM) i	0.70	0.37
Price to Book (MRQ) i	0.26	0.76
Market Capitalization
Market Capitalization i	$32.08M	$380.88M
Enterprise Value i	$409.73M	$675.49M
Enterprise Value Metrics
Enterprise to Revenue i	1.50	0.42
Enterprise to EBITDA i	676.12	4.31
Risk & Other Metrics
Beta i	-0.53	0.89
Book Value per Share (MRQ) i	$5.91	$15.91

Financial Statements Comparison: Waldencast plc vs Nu Skin Enterprises

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	WALD	NUS
Revenue/Sales i	$0	$364.49M
Cost of Goods Sold i	N/A	$117.53M
Gross Profit i	N/A	$246.96M
Research & Development i	N/A	N/A
Operating Income (EBIT) i	$-4.40M	$15.21M
EBITDA i	$-11.30M	$1.04M
Pre-Tax Income i	$2.77M	$134.60M
Income Tax i	N/A	$27.09M
Net Income (Profit) i	$2.77M	$107.52M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	WALD	NUS
Cash & Equivalents i	$14.80M	$203.77M
Total Current Assets i	$103.62M	$524.86M
Total Current Liabilities i	$76.89M	$260.30M
Long-Term Debt i	$149.86M	$280.71M
Total Shareholders Equity i	$729.94M	$753.97M
Retained Earnings i	$-289.20M	$1.82B
Property, Plant & Equipment i	$0	$459.46M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	WALD	NUS
Operating Cash Flow i	$5.41M	$130.69M
Capital Expenditures i	N/A	$-13.58M
Free Cash Flow i	$-1.59M	$-13.20M
Debt Repayment i	N/A	$-155.62M
Common Stock Repurchase i	N/A	$-5.01M

Short Interest & Institutional Ownership Analysis

Metric	WALD	NUS
Shares Short i	585,305	1.83M
Short Ratio i	4.43	3.16
Short % of Float i	0.01%	0.04%
Average Daily Volume (10 Day) i	870,850	576,200
Average Daily Volume (90 Day) i	385,483	595,333
Shares Outstanding i	122.50M	49.81M
Float Shares i	32.85M	48.32M
% Held by Insiders i	0.57%	0.02%
% Held by Institutions i	0.30%	0.75%

Dividend Analysis & Yield Comparison: Waldencast plc vs Nu Skin Enterprises

Metric	WALD	NUS
Last 12-Month Dividend i	N/A	$0.18
Last 12-Month Dividend Yield i	N/A	2.32%
3-Year Avg Annual Dividend i	N/A	$0.75
3-Year Avg Dividend Yield i	N/A	0.94%
3-Year Total Dividends i	N/A	$2.25
Ex-Dividend Date	N/A	Feb 24, 2025